Please login to the form below

Not currently logged in
Email:
Password:

NICE appoints Mark Baker and Alexia Tonnel as directors

Baker becomes director of the centre for clinical practice while Tonnel takes over as director of evidence resources

The UK's National Institute for Health and Clinical Excellence (NICE) has appointed Professor Mark Baker and Alexia Tonnel as directors.

Prof Baker will replace the departing Prof Peter Littlejohns as director of the centre for clinical practice, while Tonnel will take over the role of director of evidence resources following the retirement of Dr Fergus Macbeth.

Both new directors have previously worked for NICE, which evaluates a product's cost-effectiveness and sets clinical guidance in the NHS, for several years.

Prof Baker has been involved with the NICE Guidelines Programme for nearly a decade, has worked as a consultant adviser to the body since 2009, and has chaired two clinical guideline development groups.

His previous experience in healthcare includes serving as chief executive of Bradford Teaching Hospitals and medical director at North Yorkshire health authority, West Yorkshire strategic health authority and Leeds Teaching Hospitals.

Tonnel has been a programme director at NICE since 2010, redesigning and managing the processes for the provision of content into NHS Evidence, the online health information portal NICE runs, and leading the development of new products, including Evidence Updates.

Prior to joining NICE, Tonnel was director at professional services firms Deloitte, advising clients in the life sciences and healthcare industries.

Sir Andrew Dillon, chief executive of NICE, said of the appointments: “Both have a wealth of experience in their respective fields and I am looking forward to working with them.”

8th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics